Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Adarsh Kumbhari"'
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Therapeutic vaccines can elicit tumor-specific cytotoxic T lymphocytes (CTLs), but durable reductions in tumor burden require vaccines that stimulate high-avidity CTLs. Recent advances in immunotherapy responses have led to renewed interest in vaccin
Externí odkaz:
https://doaj.org/article/a35570015d15431e9e60a49c0e500fff
Publikováno v:
Mathematical biosciences. 334
T cells protect the body from cancer by recognising tumour-associated antigens. Recognising these antigens depends on multiple factors, one of which is T cell avidity, i.e., the total interaction strength between a T cell and a cancer cell. While bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f551cb4c60f8852ef2003709c86afe2
https://pubmed.ncbi.nlm.nih.gov/33539903
https://pubmed.ncbi.nlm.nih.gov/33539903
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Therapeutic vaccines can elicit tumor-specific cytotoxic T lymphocytes (CTLs), but durable reductions in tumor burden require vaccines that stimulate high-avidity CTLs. Recent advances in immunotherapy responses have led to renewed interest in vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e8cbccf9a51c8391e9279c8f5da002
https://www.frontiersin.org/articles/10.3389/fimmu.2020.584680/full
https://www.frontiersin.org/articles/10.3389/fimmu.2020.584680/full
SUMMARYMitochondria are the powerhouse of the cell and owing to their unique energetic demands, heart muscles contain a high density of mitochondria. In conditions such as heart failure and diabetes-induced heart disease, changes in the organization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7da642858eedb2853e95aa529bdc982e
https://doi.org/10.1101/2020.09.21.307306
https://doi.org/10.1101/2020.09.21.307306
Therapeutic vaccines can elicit tumor-specific cytotoxic T lymphocytes (CTLs), but durable reductions in tumor burden require vaccines that stimulate high-avidity CTLs. Recent advances in immunotherapy responses have led to renewed interest in vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c46474f0ffa65f0bc087c126824ba5a
https://doi.org/10.1101/2020.07.16.204966
https://doi.org/10.1101/2020.07.16.204966
Publikováno v:
Frontiers in Immunology; 10/30/2020, Vol. 11, pN.PAG-N.PAG, 14p